SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Portola Pharmaceuticals Q1 EPS $(0.880) Misses $(0.800) Estimate, Sales $26.389M Miss $33.860M Estimate

Portola Pharmaceuticals (NASDAQ:PTLA) reported quarterly losses of $(0.880) per share which missed the analyst consensus estimate of $(0.800) by 10 percent. This is a 13.73 percent increase over losses of $(1.020) per

Benzinga · 05/11/2020 12:23

Portola Pharmaceuticals (NASDAQ:PTLA) reported quarterly losses of $(0.880) per share which missed the analyst consensus estimate of $(0.800) by 10 percent. This is a 13.73 percent increase over losses of $(1.020) per share from the same period last year. The company reported quarterly sales of $26.389 million which missed the analyst consensus estimate of $33.860 million by 22.06 percent. This is a 19.04 percent increase over sales of $22.169 million the same period last year.